Sandip Kapadia Intercept Pharmaceuticals, Inc. (ICPT) insider trading activity

Sandip Kapadia is CFO and Treasurer of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 40,964 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Jan 22, 2021, when has been sold 17,200 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41K

0% 3M change

0% 12M change

Total Value Held $0

Sandip Kapadia Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 22 2021	BUY Grant, award, or other acquisition	-	17,200 Added 29.57%	40,964 Common Stock
Jan 05 2021	SELL Open market or private sale	$53,663 $24.47 p/Share	2,193 Reduced 8.45%	23,764 Common Stock
Jan 01 2021	SELL Payment of exercise price or tax liability	$8,447 $24.7 p/Share	342 Reduced 1.3%	25,957 Common Stock
Dec 31 2020	SELL Payment of exercise price or tax liability	$21,217 $24.7 p/Share	859 Reduced 3.16%	26,299 Common Stock
Dec 15 2020	SELL Open market or private sale	$57,791 $32.78 p/Share	1,763 Reduced 6.1%	27,158 Common Stock
Oct 01 2020	SELL Payment of exercise price or tax liability	$12,456 $42.08 p/Share	296 Reduced 1.01%	28,921 Common Stock

Also insider at

HRMY

Harmony Biosciences Holdings, Inc. Healthcare

CHIEF FINANCIAL OFFICER

PASG

Passage BIO, Inc. Healthcare

Sandip Kapadia

CFO and Treasurer

Plymouth Meeting, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ICPT shares.

Notify only if

Value

Insider Trading

Get notified when an Intercept Pharmaceuticals, Inc. insider buys or sells ICPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to INTERCEPT PHARMACEUTICALS, INC.

Account